Loading clinical trials…
Loading clinical trials…
Clinical trials · failure tracking
Oncology studies whose overall status is TERMINATED, WITHDRAWN or SUSPENDED on ClinicalTrials.gov, with the stop reason exactly as the registrant posted it. A category is attached only when an explicit keyword rule matches the text; CancerIndex never infers why a study stopped.
2,226 stopped studies mapped to Malignant Genitourinary System Neoplasm and descendants · 88% state a reason
Over the 2,226 studies matching the cancer, status and year filters (the category filter does not change this chart). Each study is counted once, in the first matching category; greyed bars are studies whose text matched no rule or was empty.
Computedrules ci-stop-reasons-v1 · keyword matching only
A category is assigned when one of its keywords appears in the posted text (case-insensitive, whole words). Rules are tested in this order and the first match wins; every match is kept in the API (reasonMatches).
| NCT | Title | Phase | Status | First posted | Lead sponsor | Why stopped (as posted) | Category |
|---|---|---|---|---|---|---|---|
| NCT00691899 | A Study to Assess the Effects of MK0822 in Prolonging Time to First Bone Metastasis in… | Phase 3 | withdrawn | Jun 6, 2008 | Merck Sharp & Dohme LLC | Withdrawn for administrative reasons | Other (stated, no rule matched) |
| NCT00022633 | S0028, Gemcitabine and Paclitaxel in Treating Patients With Advanced or Recurrent Cancer… | Phase 2 | terminated | Jan 27, 2003 | SWOG Cancer Research Network | Permanently Closed Due to Poor Accrual | Enrollment / accrual |
| NCT02281279 | Rituximab, Romidepsin, and Lenalidomide in Treating Patients With Recurrent or Refractory… | Phase 1 / Phase 2 | withdrawn | Nov 3, 2014 | Mayo Clinic | not stated | Not stated |
| NCT02083536 | LDFWART With Docetaxel in Patients With Platinum-Resistant Recurrent Ovarian Carcinoma | Phase 1 | withdrawn | Mar 11, 2014 | University of Miami | Study voluntarily stopped by Principal Investigator due to lack of accrual. | Investigator |
| NCT01555073 | Preemptive Analgesia Following Uterine Artery Embolization | Phase 4 | terminated | Mar 15, 2012 | Northwestern University | Subjects did not meet inclusion criteria | Other (stated, no rule matched) |
| NCT00318110 | Matched Unrelated Donor Transplant for Metastatic Renal Cell Carcinoma | Phase 2 | terminated | Apr 26, 2006 | Center for International Blood and Marrow Transplant Research | Unable to meet subject enrollment goal. | Enrollment / accrual |
| NCT02627430 | Talazoparib and HSP90 Inhibitor AT13387 in Treating Patients With Metastatic Advanced… | Phase 1 | withdrawn | Dec 11, 2015 | National Cancer Institute (NCI) | Other - Protocol moved to Withdrawn | Other (stated, no rule matched) |
| NCT01379378 | Male Stress Urinary Incontinence and Sexual Health | — | withdrawn | Jun 23, 2011 | Stanford University | not stated | Not stated |
| NCT02678520 | Clinical Trial Comparing 3-D RT vs. IMRT in Post- Prostatectomy Prostate Cancer Patients | Phase 2 | withdrawn | Feb 9, 2016 | University of Kansas Medical Center | PI no longer at institution. Study terminated prior to enrolling subjects. | Enrollment / accrual |
| NCT01336231 | Impact on Quality of Life, Fatigue and Cognitive Function in Anti-angiogenesis in…(COG-ANGIO) | — | terminated | Apr 15, 2011 | Centre Francois Baclesse | lack of recruitment | Enrollment / accrual |
| NCT01652014 | Single or Double Donor Umbilical Cord Blood Transplant in Treating Patients With… | Phase 2 | withdrawn | Jul 27, 2012 | University of Medicine and Dentistry of New Jersey | Funding unavailable | Funding |
| NCT00003858 | Mitoxantrone Following Surgery in Treating Patients With Prostate Cancer at High Risk for… | Phase 2 | withdrawn | Sep 14, 2004 | Alliance for Clinical Trials in Oncology | The study was not activated. | Other (stated, no rule matched) |
| NCT01481441 | Quantification of Contrast Enhanced Ultrasound (CEUS) in the Detection of Prostate Cancer(AMC_2011_190) | N/A | terminated | Nov 29, 2011 | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | New study protocol started including targeted biopsies | Other (stated, no rule matched) |
| NCT01326390 | Impact of C-arm CT in Decreased Renal Function Undergoing TACE for Tx of Hepato-Cellular… | — | terminated | Mar 30, 2011 | Stanford University | not stated | Not stated |
| NCT00861471 | Docetaxel (Taxotere) and Imatinib Mesylate (Gleevec) in Hormone Refractory Prostate Cancer | Phase 1 / Phase 2 | terminated | Mar 13, 2009 | NYU Langone Health | due to slow accrual | Enrollment / accrual |
| NCT01003938 | Topotecan With Erlotinib for Topotecan Pretreated Ovarian Cancer | Phase 2 | terminated | Oct 29, 2009 | NYU Langone Health | due to administrative issue and financial sponsor decision to suspend ovarian cancer studies | Funding |
| NCT00003682 | Methylprednisolone With or Without Doxorubicin in Treating Patients With Metastatic… | Phase 3 | terminated | Jan 27, 2004 | UNICANCER | lack of inclusions | Other (stated, no rule matched) |
| NCT00003852 | Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients… | Phase 2 | terminated | Jan 27, 2004 | UNICANCER | lack of patient inclusion | Other (stated, no rule matched) |
| NCT01339000 | Improving the Immune System With Human IL-7 Vaccine in Older Subjects Who Have Had… | Phase 2 | terminated | Apr 20, 2011 | National Cancer Institute (NCI) | Company supplying drug declared bankruptcy, thus there was no drug supply. | Drug supply |
| NCT00664196 | Trial of Anti-PSMA Designer T Cells in Advanced Prostate Cancer After Non-Myeloablative… | Phase 1 | suspended | Apr 22, 2008 | Roger Williams Medical Center | Funding | Funding |
| NCT02140138 | An Open Label Randomised Trial of RNActive® Cancer Vaccine in High Risk and Intermediate… | Phase 2 | terminated | May 16, 2014 | CureVac | Recruitment was terminated after enrolment of 35 instead of 36 evaluable patients for… | Enrollment / accrual |
| NCT01658527 | TAK-700 in Castration Resistant Prostate Cancer | Phase 2 | withdrawn | Aug 7, 2012 | European Organisation for Research and Treatment of Cancer - EORTC | Pharmaceutical company has terminated orteronel (TAK-700) development for Prostate Cancer | Sponsor / business decision |
| NCT00503984 | A Phase I/II Study of Azacitidine, Docetaxel, and Prednisone for Metastatic Prostate… | Phase 1 / Phase 2 | terminated | Jul 19, 2007 | University of Miami | Withdrawal of Funding | Funding |
| NCT00671606 | Hysteroscopic Lymphatic Mapping for Endometrial Cancer | Phase 2 | terminated | May 5, 2008 | M.D. Anderson Cancer Center | Slow accrual. | Enrollment / accrual |
| NCT00216060 | Risedronate to Prevent Skeletal Related Events in Patients With Metastatic Prostate… | Phase 3 | terminated | Sep 22, 2005 | Christopher Sweeney, MBBS | Terminated due to low accrual | Enrollment / accrual |
| NCT01173146 | Imaging of Residual Tumor During Prostatectomy | — | withdrawn | Jul 30, 2010 | Spectros Corporation | Costs for antibody production rose; supplemental funding request not approved. | Funding |
| NCT00985738 | Role of Dutasteride in Patients Undergoing 3D Mapping Biopsy in Early Stage Prostate… | Phase 2 | terminated | Sep 28, 2009 | University of Colorado, Denver | Low recruitment | Enrollment / accrual |
| NCT00801996 | Epidemiologic, Clinical and Genetic Profile of Prostate Cancer in Arab Countries(ProstateCA) | — | withdrawn | Dec 4, 2008 | Weill Medical College of Cornell University | Closed by Investigator | Investigator |
| NCT01356329 | Efficacy and Safety of the LovenoxTM (Enoxaparin) Versus HeparinTM Gynecologic Oncology…(Lovenox) | Phase 3 | suspended | May 19, 2011 | National Guard Health Affairs | Difficulty in enrolling patients | Enrollment / accrual |
| NCT00529464 | Spectroscopy Versus Standard Care in Cervical Cancer Patients | Phase 3 | terminated | Sep 14, 2007 | M.D. Anderson Cancer Center | Two participants enrolled, both inevaluable. | Enrollment / accrual |
| NCT01981707 | F-choline PET in Early Response Assessment for Castration Resistant Prostatic Cancer(PRECHOL) | Phase 2 / Phase 3 | terminated | Nov 11, 2013 | University Hospital, Grenoble | enrollment default | Enrollment / accrual |
| NCT02512120 | Volume Controlled Ventilation vs Autoflow-volume Controlled Ventilation(VCVAFVCV) | N/A | withdrawn | Jul 30, 2015 | Korea University Anam Hospital | The backgroud of this study was not well discussed. | Other (stated, no rule matched) |
| NCT02749825 | Comparison of Trelstar Versus Lupron or Zoladex in Advanced Prostate Cancer | Phase 4 | terminated | Apr 25, 2016 | Pharmatech | Withdrawal of funding support | Funding |
| NCT01832831 | Anatomical and Functional Differences Between Continent and Incontinent Men Post Radical… | — | terminated | Apr 16, 2013 | University of Michigan | The study was completed as planned | Other (stated, no rule matched) |
| NCT00634894 | Femara (Letrozole) Versus Placebo for Patients With Ovarian, Fallopian Tube, or Primary… | Phase 2 | withdrawn | Mar 13, 2008 | M.D. Anderson Cancer Center | Study halted with no registration, the drug company sponsor withdrew support. | Sponsor / business decision |
| NCT02718742 | Paclitaxel Albumin-Stabilized Nanoparticle Formulation After Cisplatin-Based Chemotherapy… | Phase 2 | withdrawn | Mar 24, 2016 | Mayo Clinic | not stated | Not stated |
| NCT00243646 | Implant and External Radiation for Prostate Cancer With or Without Hormonal Therapy: A… | Phase 3 | terminated | Oct 24, 2005 | Schiffler Cancer Center | poor accrual | Enrollment / accrual |
| NCT02479178 | A Study of BIND-014 in Patients With Urothelial Carcinoma, Cholangiocarcinoma, Cervical…(iNSITE2) | Phase 2 | terminated | Jun 24, 2015 | BIND Therapeutics | not stated | Not stated |
| NCT02110849 | Prostate Cancer Parameters for Patients Receiving Proton Treatment | — | withdrawn | Apr 10, 2014 | Indiana University | Closure of IU Health Proton Facility | Other (stated, no rule matched) |
| NCT00556205 | Bevacizumab With or Without Sunitinib in Sunitinib-Refractory Renal Cell Carcinoma | Phase 2 | withdrawn | Nov 9, 2007 | Massachusetts General Hospital | Toxicity of combination from other trials | Safety / toxicity |
| NCT00024167 | Chemotherapy With or Without Strontium-89 in Treating Patients With Prostate Cancer | Phase 3 | terminated | Jan 27, 2003 | M.D. Anderson Cancer Center | Terminated due to slow accrual | Enrollment / accrual |
| NCT00831480 | Everolimus (RAD001) For Advanced Renal Cell Carcinoma (RCC) Before Kidney Removal | Phase 2 | terminated | Jan 29, 2009 | Linda C. Higgins | Difficulty in accrual and by the order of the cancer center. | Enrollment / accrual |
| NCT00440973 | Safety Study of Specific Tumor Target Drug Plus Immune System Therapy in Patients With… | Phase 2 | terminated | Feb 27, 2007 | The Methodist Hospital Research Institute | contract issues | Other (stated, no rule matched) |
| NCT00522249 | Study of Pegylated Alfa Interferon, Sunitinib and Tarceva in Patients With Metastatic RCC | Phase 1 / Phase 2 | terminated | Aug 29, 2007 | The Methodist Hospital Research Institute | PI decision | Other (stated, no rule matched) |
| NCT01603420 | External Beam Radiation With or Without Chemotherapy to Treat High Risk Prostate Cancer | Phase 2 / Phase 3 | terminated | May 22, 2012 | Proton Collaborative Group | enrollment goals not met | Enrollment / accrual |
| NCT01675011 | Embozene Microspheres for Uterine Fibroid Embolization (UFE) | N/A | terminated | Aug 29, 2012 | Boston Scientific Corporation | Inadequate enrollment | Enrollment / accrual |
| NCT00526799 | Sorafenib + Topotecan for Platinum-Resistant Recurrent Ovarian Cancer | Phase 1 / Phase 2 | terminated | Sep 10, 2007 | Daniela Matei, MD | Study closed to accrual due unfavorable interim analysis | Efficacy / futility |
| NCT01220427 | Micro-RNA Expression Profiles in High Risk Prostate Cancer | — | terminated | Oct 13, 2010 | Wuerzburg University Hospital | not stated | Not stated |
| NCT02307474 | A Pilot Study of SBRT With Adjuvant Pazopanib for Renal Cell Cancer | N/A | withdrawn | Dec 4, 2014 | Case Comprehensive Cancer Center | Funding Unavailable | Funding |
| NCT00522301 | Sorafenib in Treating Patients With Ovarian Epithelial Cancer, Fallopian Tube Cancer, or… | Phase 2 | terminated | Aug 29, 2007 | Memorial Sloan Kettering Cancer Center | not stated | Not stated |
Stop reasons are registrant-reported free text and are displayed verbatim (truncated; hover for the full text). Categories come from explicit keyword rules and are never inferred from the study design, sponsor or outcome; a study that stopped for several reasons is filed under the first rule that matched. A TERMINATED status does not imply a negative result.
Data updated 24 days agoSource updated Aug 12, 2016source: clinicaltrials